Literature DB >> 16027344

Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients.

Nathan Monhian1, Brian S Jewett, Shan R Baker, James Varani.   

Abstract

OBJECTIVE: To obviate the difficulty of ruling out confounding variables (eg, age, individual variability) as the source of differences seen when comparing tumor tissue and control tissue from unrelated individuals, we examined the expression of matrix metalloproteinase (MMP)-1 (interstitial collagenase) and MMP-9 (92-kDa gelatinase B) in histologically normal skin immediately adjacent to basal cell carcinomas (peritumoral tissue) after Mohs micrographic surgery and postauricular skin from the same patients.
DESIGN: Peritumoral and postauricular skin samples were obtained from 17 patients undergoing Mohs surgery. Expression of MMP-1 and MMP-9 was examined in these specimens using a combination of approaches including zymography, collagen-degradation assays, and immunohistology.
RESULTS: The expression levels of MMP-1 and MMP-9 were consistently elevated in the peritumoral tissue compared with skin from the distal site.
CONCLUSION: This finding indicates that even when potentially important variables such as age and individual variability are controlled for, tumor-specific effects on the expression of MMP-9 and MMP-1 remain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027344     DOI: 10.1001/archfaci.7.4.238

Source DB:  PubMed          Journal:  Arch Facial Plast Surg        ISSN: 1521-2491


  15 in total

1.  Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.

Authors:  Ivana Manola; Ana Mataic; Daniela Ledic Drvar; Ivan Pezelj; Tihana Regovic Dzombeta; Bozo Kruslin
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

3.  Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid.

Authors:  Zornitsa I Zlatarova; Ekaterina B Softova; Klara G Dokova; Elisabeth M Messmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

4.  Proteins involved in cutaneous basal cell carcinoma development.

Authors:  Magdalena Ciążyńska; Igor A Bednarski; Karolina Wódz; Paweł Kolano; Joanna Narbutt; Michał Sobjanek; Anna Woźniacka; Aleksandra Lesiak
Journal:  Oncol Lett       Date:  2018-07-11       Impact factor: 2.967

5.  Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls.

Authors:  Sonja Boyd; Kalle Tolvanen; Susanna Virolainen; Tiina Kuivanen; Lauri Kyllönen; Ulpu Saarialho-Kere
Journal:  Virchows Arch       Date:  2007-11-22       Impact factor: 4.064

6.  Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical study.

Authors:  Taku Fujimura; Aya Kakizaki; Yumi Kambayashi; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-06-05

7.  Optical delineation of human malignant melanoma using second harmonic imaging of collagen.

Authors:  C Thrasivoulou; G Virich; T Krenacs; I Korom; D L Becker
Journal:  Biomed Opt Express       Date:  2011-04-20       Impact factor: 3.732

8.  Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate.

Authors:  Masaya Ishibashi; Taku Fujimura; Akira Hashimoto; Takahiro Haga; Kaoru Onami; Akira Tsukada; Yumi Kambayashi; Takanori Hidaka; Sadanori Furudate; Ryoko Shimada; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-01-11

9.  Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.

Authors:  Taku Fujimura; Sadanori Furudate; Yumi Kambayashi; Setsuya Aiba
Journal:  Clin Dev Immunol       Date:  2013-03-31

10.  PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts.

Authors:  Alexandre Valin; Stéphanie Barnay-Verdier; Thomas Robert; Hugues Ripoche; Florence Brellier; Odile Chevallier-Lagente; Marie-Françoise Avril; Thierry Magnaldo
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.